Table of Contents

Saxenda (liraglutide) is an FDA-approved GLP-1 receptor agonist for chronic weight management for adults with a BMI greater than or equal to 30 (obese) or 27 (overweight with comorbidities) and for pediatric patients (12+ years) with high BMI. It is used alongside a reduced-calorie diet and physical activity.

The FDA approved Saxenda after Phase III trials with over 5,000 in 56 weeks. Participants achieved greater than or equal to 5% and 10% weight loss compared to placebo. They received 3 mg doses alongside diet and exercise counseling. Serious side effects included pancreatitis, gallbladder disease, renal issues, and suicidal thoughts.

Using Saxenda involves an injectable pen, which may seem complex at first. However, understanding the dosing and administration process is essential for achieving optimal results. This guide offers clear, step-by-step Saxenda dosing instructions to help you use the medication effectively and with confidence.

Key Takeaways

  • Saxenda is administered as a once-daily injection with doses starting at 0.6 mg and gradually increasing to a target dose of 3 mg by week five.
  • The dosing schedule for Saxenda is designed to gradually adjust the body to the medication, minimizing gastrointestinal side effects.
  • If Saxenda is not well-tolerated at higher doses, the dosage can be reduced or the titration period extended.
  • If more than three days are missed, restart Saxenda at the initial dose of 0.6 mg and follow the standard titration schedule to avoid side effects.
  • Patients should rotate injection sites to minimize the risk of skin irritation and avoid injecting in the same spot repeatedly.

Saxenda Dosage Forms

Saxenda is available as a 6 mg/mL solution in a 3 mL pre-filled pen designed for your single use. The pen allows you to adjust the dose, delivering the following amounts:

                        • 0.6 mg
                        • 1.2 mg
                        • 1.8 mg
                        • 2.4 mg
                        • 3 mg
Saxenda | Pharma Giant

Saxenda Dosing Chart

Here’s your Saxenda dosing chart, designed to guide you through a once-daily injection schedule:

Week Dose
Week 1 0.6 mg/day
Week 2 1.2 mg/day
Week 3 1.8 mg/day
Week 4 2.4 mg/day
Week 5 3 mg/day

Saxenda Dosing Schedule

Saxenda’s dosing schedule is designed to to help minimize gastrointestinal side effects, ensuring a smoother experience as you progress with your treatment.

Week 1: Starting with 0.6 mg per day

You’ll begin with a once-daily dose of 0.6 mg to help your body adjust to Saxenda, minimizing the risk of side effects like nausea, diarrhea, constipation, vomiting, and dizziness. This lower dose prepares your body for the more effective doses to come.

Week 2: Increasing to 1.2 mg

By week two, your dose will increase to 1.2 mg. This gradual rise helps your body continue adapting to Saxenda while starting to support appetite control and weight management.

Week 3: Moving up to 1.8 mg

By the third week, your dose will increase to 1.8 mg. Studies show that Saxenda at this dose can help lower your blood sugar levels and reduce your body weight by up to 10.7 lbs (4.87 kg). While Saxenda won’t significantly increase your risk of severe hypoglycemia, it may raise the likelihood of gastrointestinal issues like nausea and vomiting.

Week 4: Raising the dose to 2.4 mg

By the fourth week, your dose will increase to 2.4 mg. At this stage, Saxenda can better support your weight management, and your body will have had time to adjust comfortably to the medication. Research shows that 2.4 mg of Saxenda resulted in a significant weight loss of 13.8 lbs or 6.3 kg, compared to 6.17 lbs or 2.8 kg with placebo.

Week 5: Reaching the target dose of 3 mg

By week five, you’ll reach the recommended target dose of 3 mg. This optimal dosage is designed to maximize weight loss and appetite suppression as part of your overall weight management plan.

Four randomized controlled trials (RCTs) showed that daily Saxenda 3 mg, along with diet and exercise, resulted in significant and meaningful weight loss compared to placebo. The studies found that Saxenda 3 mg significantly increased the chances of achieving at least a 5% or more than 10% reduction in body weight. These benefits were observed across various patient groups, including those without diabetes, with prediabetes, T2DM, and obstructive sleep apnea (OSA).

A Saxenda user shared on Reddit that she was experiencing constant nausea and indigestion at 3.0 mg. Her doctor advised her to lower the dose to 1.8 mg. Commenters said they still achieved their desired weight loss even in doses lower than 3 mg.

https://www.reddit.com/r/liraglutide/comments/1b1q821/saxenda_has_anyone_lowered_dose_after_reaching_3mg/

Saxenda Dosing Guide

Here’s a helpful Saxenda dosing guide to follow, whether you’re an adult or a pediatric patient:

Saxenda Dosing Guide for Adult Patients

    • If you find that you can’t tolerate the 3 mg dose, it’s important to contact your healthcare provider before adjusting your dose or changing your treatment plan.
    • If an increased dose isn’t well tolerated during escalation, you should consider extending the titration period by about one more week.
    • Your weight should be reassessed after 16 weeks on Saxenda. If you’ve lost less than 4% of your starting weight, don’t stop treatment just yet, as discontinuing early could reduce your chances of long-term weight loss success.
    • For adult patients with type 2 diabetes, monitor your blood glucose levels before starting Saxenda and throughout your treatment.

Saxenda Dosing Guide for Pediatric Patients

    • If you find that the 3 mg dose isn’t well tolerated, your dose may be adjusted to 2.4 mg daily.
    • During dose escalation, if you experience any issues with an increased dose, the dose can be reduced back to the previous level for up to 8 weeks. In pediatric patients, dose escalation can take up to 8 weeks.
    • Your BMI should be reassessed after 12 weeks on the maintenance dose. If you haven’t seen at least a 1% reduction from your starting point, Saxenda should be discontinued, as continuing treatment is unlikely to result in meaningful or sustainable weight loss.

Additional Saxenda Dosing Instructions

  • Training and Preparation: Before you begin using Saxenda, make sure you receive proper injection technique training. For guidance, review the instructions for use included in the packaging.
  • Inspect the Solution: Always check Saxenda before using it. Do not use a solution that appears cloudy or has visible particles. Only inject a solution that is clear, colorless, and free of particles.
  • Injection Schedule: Inject Saxenda subcutaneously once daily at any time that works best for you, regardless of meals. You can use your abdomen, thigh, or upper arm as injection sites.
  • Rotating Injection Sites: To minimize the risk of skin buildup, be sure to rotate injection sites within the same area. Avoid injecting in the same spot repeatedly.
  • Missed Dose: If you miss a dose, continue with your regular once-daily schedule for the next dose. Do not take an extra dose to make up for a missed one. If it’s been more than 3 days since your last dose, restart at 0.6 mg daily and follow the regular dose escalation schedule to reduce the chance of gastrointestinal side effects.

Final Insights

Saxenda can be a powerful tool for your weight loss journey when paired with a healthy diet and regular exercise. In order to gradually increase the drug’s effectiveness and minimize the side effects, you should follow the Saxenda dosing instructions carefully. Also, tracking your progress such as your body weight is highly recommended. If you ever have questions or experience any challenges with the medication, reach out to your healthcare provider for personalized guidance and support.

Frequently Asked Questions

The list price of Saxenda is $1,349.02. You can also buy the drug on online drug stores such as Pharma Giant with a starting price of $515.
Significant weight loss with Saxenda (liraglutide 3.0 mg) can typically be observed within 4 to 6 months of starting the treatment, especially when combined with diet and exercise. In a study with 311 participants, those using Saxenda for at least 4 months experienced an average weight loss of 15.4 lbs or 7.0 kg, while those continuing for at least 6 months lost an average of 17.6 lbs or 8.0 kg. Additionally, 64.1% of participants using Saxenda for 6 months lost at least 5% of their body weight.
Saxenda stays in your system for about three days after the last dose. It has a half-life of 13 hours, meaning half the drug is cleared every 13 hours until fully eliminated.
Saxenda and Ozempic are not the same, but both are GLP-1 receptor agonists. Saxenda (liraglutide) is used primarily for weight management, while Ozempic (semaglutide) is approved for managing type 2 diabetes and is at times prescribed off-label for weight loss. Ozempic is administered weekly, whereas Saxenda is a daily injection.
You can use Saxenda at night or at any time of day, with or without food or drinks. It’s best to use it around the same time each day, at a time that works best for the individual’s schedule.
Saxenda and Victoza both contain liraglutide but are used for different purposes. Saxenda is approved for weight management, while Victoza is prescribed for managing type 2 diabetes. They have different dosing schedules tailored to their specific uses.
Unused Saxenda pens can be stored in the refrigerator (36°F to 46°F). Once you use it, keep it in the refrigerator or at room temperature (59°F to 86°F) but discard it after 30 days, even if not empty. You should not freeze Saxenda or use it if it has been frozen.
There has yet to be an official confirmation of when a generic version of Saxenda will be available. Its patent expires on January 20, 2026, meaning Novo Nordisk has exclusive rights until that date. However, generic versions of Victoza (which also contains liraglutide) by Teva were approved on June 24, 2024.

Sources

U.S. Food and Drug Administration. (2023). Saxenda (liraglutide) injection, for subcutaneous use: Labeling information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf

Saxenda. (n.d.). About Saxenda: Dosing schedule. https://www.saxenda.com/about-saxenda/dosing-schedule.html

NovoMedlink. (n.d.). Saxenda dosing and administration. https://www.novomedlink.com/obesity/products/treatments/saxenda/dosing-administration/saxenda-dosing.html#

Mehta, A., Marso, S. P., & Neeland, I. J. (2016). Liraglutide for weight management: a critical review of the evidence. Obesity Science & Practice, 3(1), 3–14. https://doi.org/10.1002/osp4.84

National Library of Medicine. (2019). Efficacy of the glucagon-like peptide-1 receptor agonist liraglutide for weight loss in patients with obesity: A systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/31203802/

Puhl, R. (2019). Obesity: A comprehensive treatment approach for adults. Obesity, 28(1), 44-51. https://onlinelibrary.wiley.com/doi/10.1002/oby.22462

Ozempic. (n.d.). Prescribing information. https://www.ozempic.com/prescribing-information.html

U.S. Food and Drug Administration. (2017). Saxenda (liraglutide) injection, for subcutaneous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022341s027lbl.pdf

National Center for Biotechnology Information. (n.d.). Liraglutide (Subcutaneous Route). In Bookshelf (NBK594336). U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK594336/#

Saxenda. (n.d.). Support and resources: FAQs. https://www.saxenda.com/support-and-resources/faqs.html#

Baron, A. (2023). Generic weight loss drugs represent a new frontier in obesity treatment. Barron’s. https://www.barrons.com/articles/generic-weight-loss-drugs-e5a1754c

Teva Pharmaceutical Industries Ltd. (2024, June 13). Teva announces launch of authorized generic of Victoza® (liraglutide injection) 1.8mg in the United States. https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2024/Teva-Announces-Launch-of-Authorized-Generic-of-Victoza-liraglutide-injection-1.8mg-in-the-United-States/default.aspx

Saxenda. (n.d.). FAQs. https://www.saxenda.com/support-and-resources/faqs.html

Saxenda. (n.d.). Dosing schedule. https://www.saxenda.com/about-saxenda/dosing-schedule.html

Clinical Trials Arena. (n.d.). Saxenda (liraglutide) for obesity. Retrieved November 22, 2024, from https://www.clinicaltrialsarena.com/projects/saxenda-liraglutide-obesity/?cf-view

National Heart, Lung, and Blood Institute. (n.d.). Body mass index (BMI). Retrieved November 22, 2024, from https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi-m.htm

Saxenda. (2022). Saxenda patient brochure. Retrieved November 22, 2024, from https://www.saxenda.com/content/dam/obesity/saxenda/pdfs/US22SX00086_SAX_Patient_Brochure_Digital_V4.pdf